GlassScriptPhysician profile
Jorawer Singh
NPI 1346660974
$4,980.63
in general payments reported to CMS, 2019-2025
19 companies · $181 in 2025
The $181 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,363 · 2020: $953 · 2021: $117 · 2022: $526 · 2023: $1,498 · 2024: $342 · 2025: $181.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,316 · Food and Beverage: $706.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,315.78 |
| Food and Beverage | $706.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Carl Zeiss Meditec USA, INC. | $1,459.99 | 2022-2023 | Cirrus Hd-Oct, Artevo 800, Visumax |
| Biotissue Holdings INC. | $697.59 | 2019-2022 | |
| Kala Pharmaceuticals, INC. | $508.12 | 2019-2020 | |
| Abbvie INC. | $454.63 | 2022-2024 | Xen Glaucoma Treatment System, Durysta |
| Novartis Pharmaceuticals Corporation | $388.75 | 2019-2020 | |
| Glaukos Corporation | $325.21 | 2019-2025 | Idosetr |
| Allergan, INC. | $233.99 | 2020-2022 | |
| Alcon Vision LLC | $207.03 | 2020-2021 | |
| Bausch & Lomb Americas INC. | $132.36 | 2025 | Stellaris |
| Mallinckrodt Enterprises LLC | $120.37 | 2019 | |
| Horizon Therapeutics Plc | $110.50 | 2022 | |
| Lensar, INC. | $83.52 | 2021-2025 | Lensar Laser System |
| Aerie Pharmaceuticals, INC. | $68.03 | 2019 | |
| Johnson & Johnson Surgical Vision, INC. | $67.78 | 2022 | |
| Sun Pharmaceutical Industries INC. | $42.06 | 2019-2020 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dompe US, INC. | $24.61 | 2020 | |
| Shire North American Group INC | $23.29 | 2019 | |
| Ocular Therapeutix, INC. | $19.81 | 2020 | |
| Mallinckrodt Hospital Products INC. | $12.99 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jorawer Singh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.